UNSPSC 85512714: Supplement left internal iliac artery with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left internal iliac artery with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UF3JZ

UNSPSC 85512714, Supplement left internal iliac artery with synthetic substitute, percutaneous approach, is a Commodity code that the recent state and local contracting record does not support with relevant procurement activity. The code describes a specific surgical procedure — vascular intervention using synthetic materials — but the recent opportunities posted under this code taxonomy reflect general health benefit administration, occupational medical surveillance, independent medical evaluation services, and temporary health professional staffing. None of the six recent solicitations involves procurement of medical devices, surgical supplies, implants, or procedure-specific materials aligned with the code's scope. The issuing bodies in the recent record span city retirement boards, county health systems, state transportation agencies, county probation departments, and county commissioners' offices — a wide issuer mix typical of government health and benefits contracting — but their work falls outside vascular surgical supply or interventional device procurement.

The geographic spread in the recent record includes Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara), Florida (Collier County), Texas (Harris County), and Washington State (WSDOT), with no concentration in any region. However, this geographic distribution reflects the absence of meaningful activity under the code itself rather than active procurement interest. The code shows no substantive recent opportunities for business development pursuit. A firm specializing in vascular surgical implants, synthetic graft materials, or interventional cardiology device supply would find no market signal in the current state and local record under this classification.